Stock Review for Medical Equipment’s Investors — Prestige Brands, Senseonics, NovoCure, and Varian Medical Systems

December 14, 2017 | By - | Filed in: Press Releases.

NEW YORK, December 14, 2017 /PRNewswire/ —

In keeping with the commitment to dynamically provide members with timely information, has issued free tailored Stock Review on PBH, SENS, NVCR, and VAR which is a click away at On Wednesday, December 13, 2017, the NASDAQ Composite ended the trading session at 6,875.80, up 0.20%; the Dow Jones Industrial Average edged 0.33% higher, to finish at 24,585.43; and the S&P 500 closed at 2,662.85, slightly dropping 0.05%. US markets saw seven out of nine sectors finishing the day in green and two in red. This Thursday, has initiated reports coverage on the following Medical Appliances & Equipment equities: Prestige Brands Holdings Inc. (NYSE: PBH), Senseonics Holdings Inc. (NYSE AMER: SENS), NovoCure Ltd (NASDAQ: NVCR), and Varian Medical Systems Inc. (NYSE: VAR). Sign up today for free and learn why our members refer to our research coverage as the ‘best out there:

Prestige Brands Holdings 

Tarrytown, New York headquartered Prestige Brands Holdings Inc.’s stock finished Wednesday’s session 0.85% lower at $46.55 with a total trading volume of 374,600 shares. The Company’s shares have advanced 12.25% in the last month. The stock is trading above its 50-day moving average by 2.10%. Additionally, shares of Prestige Brands, which through its subsidiaries, markets, sells, manufactures, and distributes over-the-counter healthcare and household cleaning products in North America, Australia, and internationally, have a Relative Strength Index (RSI) of 57.48.

On December 04th, 2017, research firm William Blair upgraded the Company’s stock rating from ‘Market Perform’ to ‘Outperform’. Signing up now gives you access to the free research coverage on PBH at:

Senseonics Holdings 

On Wednesday, shares in Germantown, Maryland headquartered Senseonics Holdings Inc. recorded a trading volume of 157,124 shares. The stock ended the session 0.77% higher at $2.63. The stock is trading above its 200-day moving average by 16.18%. Moreover, shares of Senseonics, which designs, develops, and commercializes glucose monitoring systems for people with diabetes primarily in Europe, have an RSI of 45.01. Get access to our top-rated research, including the free report on SENS at:


Saint Helier, the Channel Islands-based NovoCure Ltd’s shares closed the day 2.20% lower at $20.05. The stock recorded a trading volume of 1.17 million shares, which was above its three months average volume of 1.01 million shares. The Company’s shares have gained 17.60% in the last month, 122.78% over the last twelve months, and 155.41% since the start of the year. The stock is trading above its 50-day and 200-day moving averages by 5.32% and 25.57%, respectively. Additionally, shares of NovoCure, which engages in the development, manufacture, and commercialization of tumor treating fields for the treatment of solid tumors, have an RSI of 56.74. Click here to subscribe for a free membership which welcomes you with our report on NVCR at:

Varian Medical Systems 

Shares in Palo Alto, California headquartered Varian Medical Systems Inc. finished 0.87% higher at $112.42. The stock recorded a trading volume of 1.02 million shares, which was above its three months average volume of 761.16 thousand shares. The Company’s shares have advanced 37.71% over the last twelve months, and 41.40% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 5.29% and 12.28%, respectively. Furthermore, shares of the Company, which designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide, have an RSI of 64.11. Join our big investor community at Wall St. Equities today and start so with your free report on VAR at:

Wall St. Equities: 

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

WSE has not been compensated; directly or indirectly; for producing or publishing this document. 


The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  


WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 


This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

For any questions, inquiries, or comments reach out to us directly. If youre a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Phone number: +21-32-044-483
Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Wall St. Equities

To post and circulate your own press release on FIR and the eTN Network  please click here 


Comments are closed here.